NCT03605082

A Study to Test the Safety and Tolerability and Pharmacokinetics of Single Doses of UCB0107 in Healthy Japanese Subjects

A Single-center, Investigator-blind, Subject Blind, Randomized, Placebo-controlled Study to Evaluate Safety and Tolerability and Pharmacokinetics of Single Doses of UCB0107 in Healthy Japanese Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: UCB Biopharma S.P.R.L. · Industry
• Sex: All
• Age: 20 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The purpose of the study is to evaluate the safety and tolerability and serum Pharmacokinetics (PK) of single doses of UCB0107 administered in healthy Japanese subjects.

Conditions

• Healthy Japanese Volunteers

Interventions

Type	Name	Description
DRUG	UCB0107	* Pharmaceutical form: solution for infusion * Route of administration: intravenous use
OTHER	Placebo	* Pharmaceutical form: solution for infusion * Route of administration: intravenous use

Timeline

• Start date: 2018-07-25
• Primary completion: 2019-03-11
• Completion: 2019-03-11
• First posted: 2018-07-30
• Last updated: 2019-03-14

Locations

1 site across 1 country: United Kingdom